Trending Alert: These 5 Companies Are Trending Now

Tickers Inside Powered by [FinancialMarketMovers.com]( Good Morning! Below is a list of 5 stocks that are trending with positive investor sentiment, news headlines, and buy ratings from top Wall Street analysts. Our editors are keeping an eye on these stocks and adding them to our watchlist to see if the momentum continues. --------------------------------------------------------------- Sponsor [Energy Storage Trend Ignites Frenzy Over Vanadium Supply]( [See how investors could benefit from domestic vanadium discoveries.]( --------------------------------------------------------------- [Alteryx, AYX]( Summary: Alteryx, Inc. provides self-service data analytics software platform. The Company's product consists of Alteryx Designer, Alteryx Server and Alteryx Analytics Gallery. Alteryx Designer offer data preparation, blending and analytics which could be deployable in the cloud and on premise; Alteryx Server, a secure and scalable product for sharing and running analytic applications in a Web-based environment and Alteryx Analytics Gallery, a cloud-based collaboration offering which allows users to share workflows in a centralized repository. Alteryx, Inc. is headquartered in Irvine, California. Yun Kim analyst at Loop Capital Markets reiterated coverage on [Alteryx (AYX)](in the Technology sector with a Hold rating and has set a price target of $48. Our data shows [Alteryx]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target of $50.55. In addition, TradingView issued a Buy rating for [AYX]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bearish short-term outlook. [For the complete breakdown on AYX, please click here >>]( [Lennar, LEN]( Summary: Lennar Corporation is engaged in homebuilding and financial services in the United States. The company's reportable segments consist of Homebuilding, Lennar Financial Services, Rialto and Lennar Multifamily. Despite the varied product portfolio, homebuilding remains Lennar's core business. Homebuilding operations include the sale and construction of single-family attached and detached homes as well as the purchase, development and sale of residential land directly and through unconsolidated entities. Aaron Hecht analyst at JMP Securities reiterated coverage on [Lennar (LEN)](in the Consumer Cyclical sector with a Buy rating and has set a price target of $170. Our data shows [Lennar]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target of $158.00. In addition, TradingView issued a Buy rating for [LEN]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the complete breakdown on LEN, please click here >>]( --------------------------------------------------------------- Sponsor [The Battery Metal Nobody Told You About]( to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech." [See why investors are taking a hard look at vanadium right now.]( --------------------------------------------------------------- [Crinetics Pharmaceuticals, CRNX]( Summary: Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States. Cory Jubinville, analyst at LifeSci Capital reiterated coverage on [Crinetics Pharmaceuticals (CRNX)](in the Healthcare sector with a Buy rating and has set a price target of $62. Our data shows [Crinetics Pharmaceuticals]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target of $51.40. In addition, TradingView issued a Strong Buy rating for [CRNX]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the complete breakdown on CRNX, please click here >>]( [Lantheus, LNTH]( Summary: Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. Richard Newitter analyst at Truist Financial reiterated coverage on [Lantheus (LNTH)](in the Healthcare sector with a Buy rating and has set a price target of $80. Our data shows [Lantheus]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target of $90.75. In addition, TradingView issued a Sell rating for [LNTH]( over the next month, Barchart.com has a sell rating and Yahoo! Finance has a Bearish short-term outlook. [For the complete breakdown on LNTH, please click here >>]( --------------------------------------------------------------- Sponsor [Rare Chance to Be an Early Investor in AI Energy Breakthrough]( expert Ian King has found a way to invest in the technology powering AI energy. A breakthrough that presents a once-in-a-lifetime opportunity for fast-acting investors. [Just go here for full details.]( --------------------------------------------------------------- [Nike, NKE]( Summary: NIKE Inc. is engaged in the business of designing, developing and marketing of athletic footwear, apparel, equipment and accessories, and services for men, women and children worldwide. With the help of a strong brand portfolio, including Nike Pro, Nike Golf, Nike and Air Jordan, it offers premium, well-designed and high-quality products, in line with the latest customer trends. NIKE is the global leader in athletic footwear, apparel, equipment and sports-related accessories. Nike's 'swoosh' logo and 'just do it' tagline are widely recognized across the world, while its association with celebrity sportspersons, such as Michael Jordon and Roger Federer as well as top professional and college teams ensures a strong brand recall in the key U.S., U.K., Japanese and Chinese markets. The company's products include six key categories: running, NIKE basketball, the Jordan brand, football, training and sportswear (sports-inspired lifestyle products). John Kernan analyst at TD Cowen reiterated coverage on [Nike (NKE)](in the Consumer Cyclical sector with a Buy rating and has set a price target of n/a. Our data shows [Nike]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target of $135.25. In addition, TradingView issued a Strong Buy rating for [NKE]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Neutral short-term outlook. [For the complete breakdown on NKE, please click here >>]( --------------------------------------------------------------- Sponsor [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- Remember, securities are volatile, so please do your own research. One resource you need to consider using [Tipranks.com]( where as a premium member you get access to all buy ratings, price targets and insider trading signals. [Get more from TipRanks.com here >>]( Thanks for reading! The Editor, [FinancialMarketMovers.com]( --------------------------------------------------------------- Sponsor [GPT-4 vs. X.AI: The Race of the New AI Giants]( smart money investors all know AI is the wave of the future and could mean huge profits for anyone involved. AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years. And right now, Chief Investment Strategist Adam O’Dell is revealing his favorite X.AI stock you should check out today. [Click here to see the full story now.]( --------------------------------------------------------------- [To Cancel Your Free Subscription, click here.]( FinancialMarketMovers.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( This is part of your free subscription to FinancialMarketMovers. FinancialMarketMovers.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy Unit 407 | Mt. Mourne | North Carolina | 28123